Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/24/2020 Oct/27/2020 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/22/2020 Oct/27/2020 0
Remdesivir Approved by FDA Experimental Antiviral Oct/20/2020 Oct/29/2020 0
Osimertinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/18/2020 Oct/10/2020 0
Simeprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/04/2020 Sep/29/2020 0
Daclatasvir Potential treatment - clinical evidence Used to treat other disease Antiviral Aug/19/2020 Sep/14/2020 0
Sofosbuvir Potential treatment - clinical evidence Used to treat other disease Antiviral Aug/19/2020 Sep/02/2020 0
Bictegravir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/11/2020 Sep/07/2020 0
Apilimod Potential treatment - pre-clinical evidence Experimental Antiviral Aug/06/2020 Aug/26/2020 0
Nelfinavir mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/05/2020 Sep/03/2020 0